Guillermo Velasco

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Venues

Cancers

Current oncology (Toronto, Ont.)

Autophagy

Nature

Universidad Complutense de Madrid

Universidad Complutense de Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Complutense de Madrid Feb 02 2008

Spain

Associate Professor (Profesor Titular) :: Biochemistry and Molecular Biology I

Education History

Universidad Complutense de Madrid Oct 01 1993 - Oct 23 1997

Spain

PHD :: Biochemistry and Molecular Biology I

Publications

Esther Cabañas Morafraile, Cristina Saiz-Ladera, Cristina Nieto-Jiménez, Gyorffy Balazs, Adam Nagy, Guillermo Velasco, Pedro Pérez-Segura, Alberto Ocaña
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers. Current oncology (Toronto, Ont.) 30 (3) (2023)
Esther Cabañas Morafraile, Cristina Saiz-Ladera, Cristina Nieto-Jiménez, Gyorffy Balazs, Adam Nagy, Guillermo Velasco, Pedro Pérez-Segura, Alberto Ocaña
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers. Current oncology (Toronto, Ont.) 30 (3) (2023)
Guillermo Velasco, Wolfgang Link
Pseudokinases, Tribbles Proteins and Cancer. Cancers 15 (14) (2023)
Esther Cabañas Morafraile, Cristina Saiz-Ladera, Cristina Nieto-Jiménez, Gyorffy Balazs, Adam Nagy, Guillermo Velasco, Pedro Pérez-Segura, Alberto Ocaña
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers. Current oncology (Toronto, Ont.) 30 (3) (2023)
Miguel Hernández-Quiles, Rosalie Baak, Alba Orea-Soufi, Anouska Borgman, Suzanne den Haan, Paula Sobrevals Alcaraz, Aldo Jongejan, Robert van Es, Guillermo Velasco, Harmjan Vos, Eric Kalkhoven
TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells. International journal of molecular sciences 23 (18) (2022)
María Martínez-García, Guillermo Velasco, Estela Pineda Losada, Miguel Gil-Gil, Francesc Alameda, Jaume Capellades, Mari Cruz Martín-Soberón, Israel López-Valero, Elena Tovar Ambel, Palmira Foro, Álvaro Taus, Montserrat Arumi, Aurelio Hernández-Laín, Juan Manuel Sepúlveda Sánchez
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. Cancers 14 (10) (2022)
Emiliano Maiani, Giacomo Milletti, Francesca Nazio, Søs Grønbæk Holdgaard, Jirina Bartkova, Salvatore Rizza, Valentina Cianfanelli, Mar Lorente, Daniele Simoneschi, Miriam Di Marco, Pasquale D Acunzo, Luca Di Leo, Rikke Rasmussen, Costanza Montagna, Marilena Raciti, Cristiano De Stefanis, Estibaliz Gabicagogeascoa, Gergely Rona, Nélida Salvador, Emanuela Pupo, Joanna Maria Merchut-Maya, Colin J Daniel, Marianna Carinci, Valeriana Cesarini, Alfie O'sullivan, Yeon-Tae Jeong, Matteo Bordi, Francesco Russo, Silvia Campello, Angela Gallo, Giuseppe Filomeni, Letizia Lanzetti, Rosalie C Sears, Petra Hamerlik, Armando Bartolazzi, Robert Edward Hynds, David R Pearce, Charles Swanton, Michele Pagano, Guillermo Velasco, Elena Papaleo, Daniela De Zio, Apolinar Maya-Mendoza, Franco Locatelli, Jiri Bartek, Francesco Cecconi
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity. Nature 592 (7856) (2021)
Alba Orea-Soufi, Sonia Castillo-Lluva, Nélida Salvador-Tormo, Paola Martín-Cabrera, Silvia Recuero, Estíbaliz Gabicagogeascoa, Manuel Moreno-Valladares, Marina Mendiburu-Eliçabe, Adrian Blanco-Gomez, Jose M Ramos Pittol, Elena García-Taboada, Alberto Ocaña, Francisco J Cimas, Ander Matheu, Isabel Álvarez-López, Guillermo Velasco, Mar Lorente
The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer. Cancers 13 (21) (2021)
Magali Humbert, María Morán, Patricia de la Cruz-Ojeda, Jordi Muntané, Tabea Wiedmer, Nadezda Apostolova, Sharon L McKenna, Guillermo Velasco, Walter Balduini, Leopold Eckhart, Bassam Janji, Belém Sampaio-Marques, Paula Ludovico, Eva Žerovnik, Rupert Langer, Aurel Perren, Nikolai Engedal, Mario P Tschan
Assessing Autophagy in Archived Tissue or How to Capture Autophagic Flux from a Tissue Snapshot. Biology 9 (3) (2020)
Parastoo Shahrouzi, Ianire Astobiza, Ana R Cortazar, Verónica Torrano, Alice Macchia, Juana M Flores, Chiara Niespolo, Isabel Mendizabal, Ruben Caloto, Amaia Ercilla, Laura Camacho, Leire Arreal, Maider Bizkarguenaga, Maria L Martinez-Chantar, Xosé R Bustelo, Edurne Berra, Endre Kiss-Toth, Guillermo Velasco, Amaia Zabala-Letona, Arkaitz Carracedo
Genomic and Functional Regulation of TRIB1 Contributes to Prostate Cancer Pathogenesis. Cancers 12 (9) (2020)
Pau Muñoz-Guardiola, Josefina Casas, Elisabet Megías-Roda, Sònia Solé, Héctor Perez-Montoyo, Marc Yeste-Velasco, Tatiana Erazo, Nora Diéguez-Martínez, Sergio Espinosa-Gil, Cristina Muñoz-Pinedo, Guillermo Yoldi, Jose Luis Abad, Miguel F Segura, Teresa Moran, Margarita Romeo, Joaquim Bosch-Barrera, Ana Oaknin, Jose Alfón, Carles Domènech, Gemma Fabriàs, Guillermo Velasco, Jose Miguel Lizcano
The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells. Autophagy 17 (6) (2020)
Mar Lorente, Ana García-Casas, Nélida Salvador, Angélica Martínez-López, Estibaliz Gabicagogeascoa, Guillermo Velasco, Lucía López-Palomar, Sonia Castillo-Lluva
Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1. Journal of cell science 132 (20) (2019)

Guillermo Velasco.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guillermo Velasco